Phase 1 Clinical Trial Demonstrated That MUC1 Positive Metastatic Seminal Vesicle Cancer Can Be Effectively Eradicated by Modified Anti-Muc1 Chimeric Antigen Receptor Transduced T Cells

Science China Life Sciences - China
doi 10.1007/s11427-016-5024-7

Related search